SANJEEV VASUDEVAN to Mechanistic Target of Rapamycin Complex 1
This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Mechanistic Target of Rapamycin Complex 1.
Connection Strength
0.061
-
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
Score: 0.033
-
mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling. Apoptosis. 2015 Jan; 20(1):50-62.
Score: 0.028